v3.26.3
DERIVATIVE FINANCIAL INSTRUMENTS - Gain (Loss) on Derivative Financial Instruments (Details) - USD ($)
$ in Millions
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives $ (22) $ 31
Amount of Gain Reclassified from AOCI into Earnings (8) 0
Cash flow hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives (11) 16
Amount of Gain Reclassified from AOCI into Earnings (8) 0
Net investment hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives (11) 15
Amount of Gain Reclassified from AOCI into Earnings 0 0
Foreign currency forward contracts | Cash flow hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives (11) 16
Foreign currency forward contracts | Net investment hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives 3 0
Amount of Gain Reclassified from AOCI into Earnings 0 0
Foreign currency forward contracts | Net investment hedges | Derivatives Designated as Hedging Instruments:    
Gain (loss) on derivative financial instruments    
Gain recognized in earnings related to the amount excluded from effectiveness testing 3 3
Foreign currency forward contracts | Location, Statement of Income, Balance [Axis]: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Cash flow hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain Reclassified from AOCI into Earnings (8) 0
Cross-currency swap contracts | Net investment hedges    
Gain (loss) on derivative financial instruments    
Amount of Gain (Loss) Recognized in OCI on Derivatives (14) 15
Amount of Gain Reclassified from AOCI into Earnings 0 0
Cross-currency swap contracts | Net investment hedges | Derivatives Designated as Hedging Instruments:    
Gain (loss) on derivative financial instruments    
Gain recognized in earnings related to the amount excluded from effectiveness testing $ 3 $ 3